By down-regulating the expression of the NCL/EBNA1/UBE2C axis using curcumol, the invasion and migration of NPC cells can be effectively inhibited, providing a new strategy and direction for the treatment of NPC (Figure 11). This evidence concerns the gene UBE2C and nasopharyngeal carcinoma.